Ascorbate uptake by ROS 17/2.8 osteoblast-like cells: substrate specificity and sensitivity to transport inhibitors.

Dixon, S J; Kulaga, A; Jaworski, E M; Wilson, J X

Dixon, S J; Kulaga, A; Jaworski, E M; Wilson, J X.

Affiliation

Dixon SJ; Division of Oral Biology, Faculty of Dentistry, University of Western Ontario, London, Canada.

J Bone Miner Res ; 6(6): 623-9, 1991 Jun.

Article in En | MEDLINE | ID: mdl-1887825

Subject(s)

Ascorbic Acid/metabolism; Osteoblasts/metabolism; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid/analogs & derivatives; 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid/pharmacology; Biological Transport/drug effects; Cells, Cultured; Furosemide/pharmacology; Kinetics; Osteoblasts/drug effects; Osteosarcoma/metabolism; Salicylates/metabolism; Salicylic Acid; Sulfinpyrazone/pharmacology; Tumor Cells, Cultured

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Osteoblasts / Ascorbic Acid Type of study: Diagnostic_studies Language: En Journal: J Bone Miner Res Journal subject: METABOLISMO / ORTOPEDIA Year: 1991 Document type: Article Affiliation country: Canada Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links